Research Article

Arterial Stiffness in Nonhypertensive Type 2 Diabetes Patients in Ghana

Table 1

Clinical characteristics of study subjects.

T2DM patients ()Controls ()

Age 51.5 ± 11.750.6 ± 11.10.733
Gender (males/females)40/5630/400.234
Alcohol intake (%)18.222.10.078
Previous smokers (%)14.37.80.428
Duration of diabetes (years)2.6 ± 1.8
FPG (mmol/L)8.4 ± 35 ± 1<0.001
2 h PPG (mmol/L)6.2 ± 2.2
HbA1c (%)8.3  ±  1.45.2  ±  0.9<0.001
Total cholesterol (mmol/L)4.1 ± 4.25.3 ± 1.4<0.001
Fasting triglycerides (mmol/L)1 ± 0.51.1 ± 0.50.310
HDL (mmol/L)0.8 ± 0.70.8 ± 0.50.793
LDL (mmol/L)4.1 ± 1.32.8 ± 1.3<0.001
BMI (kg/m2)26.5 ± 4.428.5 ± 5.30.085
Body fat (%)30.4 ± 10.133.3 ± 13.70.305
Visceral fat (%)11.1 ± 5.19.9 ± 3.10.165
Waist circumference (cm)93.9 ± 10.393.5 ± 17.50.897
Waist-hip ratio0.91 ± 0.070.92 ± 0.190.797
Arteriograph measurements
PWVao (m/s)8.3 ± 17.8 ± 1.30.004
 Aortic systolic BP (mmHg)116 ± 12119 ± 110.195
 Aortic pulse BP (mmHg)39 ± 1343 ± 140.201
 Augmentation index (%)20 ± 1225 ± 130.138
 Systolic BP (mmHg)124 ± 9124 ± 100.748
 Diastolic BP (mmHg)74 ± 774 ± 90.977
 Pulse BP (mmHg)50 ± 750 ± 80.640
 Mean BP (mmHg)116 ± 10115 ± 110.939
Heart rate (bpm)74 ± 1065 ± 110.001
Vasera measurements
 Systolic BP130 ± 11133 ± 320.613
Diastolic BP82 ± 888 ± 120.039
Pulse BP48 ± 950 ± 120.04
 Mean BP98 ± 8104 ± 140.402
Heart rate73 ± 1065 ± 120.001
CAVI7.9 ± 1.26.9 ± 0.70.021
 haPWV (m/s)7.4 ± 0.87 ± 0.80.263

BMI: body mass index; BP: blood pressure; HR: heart rate; PWVao: aortic pulse wave velocity; AIx: augmentation index; CAVI: cardioankle vascular index; haPWV: heart-ankle PWV.